SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma

NCT05896046 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Relapsed or Refractory Hodgkin Lymphoma

Interventions

DRUG: SHR2554+ SHR1701
DRUG: SHR-1701

Sponsor

Chinese PLA General Hospital